Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Hodgkin Disease 5Lymphoma, Non-Hodgkin 3Myeloproliferative Disorders 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Leukemia 2Hematologic Neoplasms 2Burkitt Lymphoma 2Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Multi-centric Castleman's Disease 1Malignant mesenchymal tumor 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lymphadenopathy 1

Interventions

Cyclophosphamide 8Mycophenolic Acid 6Whole-Body Irradiation 5Busulfan 5fludarabine phosphate 4fludarabine 4Tacrolimus 4Cyclosporine 4Rituximab 3Prednisone 3Methotrexate 3Inotuzumab Ozogamicin 3Etoposide 3Cytarabine 3venetoclax 2ruxolitinib 2pegfilgrastim 2asciminib 2Vincristine 2Peripheral Blood Stem Cell Transplantation 2Mercaptopurine 2Filgrastim 2Dexamethasone 2Calcium Dobesilate 2tocilizumab 1ricolinostat 1rasburicase 1ponatinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia × Filgrastim × 30 days × Clear all
NCT01046825 2026-06-02

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT03434730 2026-05-26

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
46 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡